GSK3B and glomerulosclerosis: Furthermore, treatment of HMC cells with the GSK3β inhibitor CHIR99021 (activator of Wnt signalling) abrogated the inhibitory effects of cyclin G2 on canonical Wnt signalling and glomerulosclerosis-related proteins.